Nice find. Looks like stock_head (which HC will obscure the URL) has credited the article but is a direct copy/pasta from biotechdaily.
Nice factual analysis and clearly explains the (sometimes misunderstood) relationships between healthcare participants and how MDR gets their slice of the pie.
And similar observations/frustrations made by Management - there are other listed companies locally and in the US with less exciting finances and prospects at much higher valuations.
I like the statement that suggests they are targeting more reach with 100M patients, but reach doesn't translate to revenue. Revenues will come from expanding interactions with the current 60M, then simply onboarding millions of untapped patients via a database.
Anzac Day next Tuesday with Monday a write off for most, then only leaves 3 days to trade.
Looking forward to the March numbers ..... hopefully this week if they're good.
Nice find. Looks like stock_head (which HC will obscure the URL)...
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.005(1.64%) |
Mkt cap ! $170.5M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $133.7K | 439.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 31062 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
30.0¢ |
Change
0.005 ( 3.59 %) |
||||
| Open | High | Low | Volume | ||
| 30.5¢ | 31.0¢ | 30.0¢ | 63006 | ||
| Last updated 15.40pm 03/05/2024 ? | |||||
| MDR (ASX) Chart |